SEC Comment Letter for AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702) (FFR) — Nov 28, 2018
AIxCrypto Holdings, Inc. (AIXC) (CIK 0001460702)
Date: Nov. 28, 2018 · CIK: 0001460702 · Accession: 0000000000-18-036544
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-228501
Letter
November 28, 2018 Andrew J. Ritter President and Chief Executive Officer Ritter Pharmaceuticals, Inc. 1880 Century Park East, Suite 1000 Los Angeles, CA 90067 Re:Ritter Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed November 21, 2018 File No. 333-228501 Dear Mr. Ritter: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Aron Izower, Esq.
Show Raw Text
November 28, 2018
Andrew J. Ritter
President and Chief Executive Officer
Ritter Pharmaceuticals, Inc.
1880 Century Park East, Suite 1000
Los Angeles, CA 90067
Re:Ritter Pharmaceuticals, Inc.
Registration Statement on Form S-3
Filed November 21, 2018
File No. 333-228501
Dear Mr. Ritter:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Aron Izower, Esq.